Education
About Us
Working with TipRanks
Follow Us
Hisamitsu Pharmaceutical Co Inc (JP:4530)
:4530
RESEARCH TOOLSreports
4530 Stock Chart & Stats
Day’s Range― - ―
52-Week Range¥3,709.00 - ¥4,735.00
Previous CloseN/A
Volume86.40K
Average Volume (3M)188.56K
Market Cap
$294.48B
Enterprise Value¥175.86B
Total Cash (Recent Filing)$116.64B
Total Debt (Recent Filing)¥2.93B
Price to Earnings (P/E)15.1
Beta0.25
Next Earnings
Oct 09, 2025EPS Estimate
137.1Next Dividend Ex-Date
Aug 28, 2025Dividend Yield2.25%
Share Statistics
EPS (TTM)62.31
Shares Outstanding75,164,894
10 Day Avg. Volume250,770
30 Day Avg. Volume188,556
Financial Highlights & Ratios
PEG Ratio0.32
Price to Book (P/B)1.04
Price to Sales (P/S)0.00
P/FCF Ratio-319.97
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
$4,662.44Price Target Upside16.39% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering0
Hisamitsu Pharmaceutical Co News
PremiumCompany Announcements
Hisamitsu Pharmaceutical Announces Share Buyback to Enhance Shareholder Value
PremiumCompany Announcements
Hisamitsu Pharmaceutical Announces Strategic Share Buyback Plan
PremiumCompany Announcements
Hisamitsu Pharmaceutical Announces Share Buyback and Cancellation Plan
PremiumCompany Announcements
Hisamitsu Pharmaceutical Co. Issues Stock Options to Align Director Interests
PremiumCompany Announcements
Hisamitsu Pharmaceutical Announces New Executive Appointments
PremiumCompany Announcements
Hisamitsu Pharmaceutical Announces Board of Directors CandidatesOptions Prices
Currently, No data available
---
Ownership Overview
―
Insiders
2.88%
Mutual Funds
― Other Institutional Investors
92.75% Public Companies and
Individual Investors
4530 FAQ
What was Hisamitsu Pharmaceutical Co Inc’s price range in the past 12 months?
Hisamitsu Pharmaceutical Co Inc lowest stock price was ¥3709.00 and its highest was ¥4735.00 in the past 12 months.
What is Hisamitsu Pharmaceutical Co Inc’s market cap?
Hisamitsu Pharmaceutical Co Inc’s market cap is $294.48B.
When is Hisamitsu Pharmaceutical Co Inc’s upcoming earnings report date?
Hisamitsu Pharmaceutical Co Inc’s upcoming earnings report date is Oct 09, 2025 which is in 78 days.
How were Hisamitsu Pharmaceutical Co Inc’s earnings last quarter?
Hisamitsu Pharmaceutical Co Inc released its earnings results on Jan 09, 2025. The company reported ¥62.31 earnings per share for the quarter, beating the consensus estimate of N/A by ¥62.31.
Is Hisamitsu Pharmaceutical Co Inc overvalued?
According to Wall Street analysts Hisamitsu Pharmaceutical Co Inc’s price is currently Undervalued.
Does Hisamitsu Pharmaceutical Co Inc pay dividends?
Hisamitsu Pharmaceutical Co Inc pays a Notavailable dividend of ¥60 which represents an annual dividend yield of 2.25%. See more information on Hisamitsu Pharmaceutical Co Inc dividends here
What is Hisamitsu Pharmaceutical Co Inc’s EPS estimate?
Hisamitsu Pharmaceutical Co Inc’s EPS estimate is 137.1.
How many shares outstanding does Hisamitsu Pharmaceutical Co Inc have?
Hisamitsu Pharmaceutical Co Inc has 75,164,894 shares outstanding.
What happened to Hisamitsu Pharmaceutical Co Inc’s price movement after its last earnings report?
Hisamitsu Pharmaceutical Co Inc reported an EPS of ¥62.31 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.173%.
Which hedge fund is a major shareholder of Hisamitsu Pharmaceutical Co Inc?
Currently, no hedge funds are holding shares in JP:4530
Company Description
Hisamitsu Pharmaceutical Co Inc
Hisamitsu Pharmaceutical Co., Inc. manufactures and sells pharmaceuticals, quasi-drugs, and medical devices in Japan. The company provides external pain relieving drugs under the SALONPAS, NOBINOBI, SALONSIP, AIR, SALONPAS, and FEITAS; and BUTENALOCK, a remedy for athlete's foot, as well as ALLEGRA FX, a sinus medication for allergies. It also manufactures and sells quasi-drugs and cosmetics; MOHRUS TAPE and MOHRUS PAP XR, transdermal analgesic anti-inflammatory drug; patches for female hormone, asthma treatment, and treatment for overactive bladders. In addition, the company manufactures and sells drugs under MOHRUS TAPE, MOHRUS PAP XR, FENTOS Tapes, NEOXY Tapes, Abstral, ALLESAGA Tapes, HARUROPI Tapes, and MENOAID Combipatch. Further, it provides HFT-290, a transdermal patch for cancer pain. The company sells its products in the United States and Asia. Hisamitsu Pharmaceutical Co., Inc. was founded in 1847 and is headquartered in Tosu, Japan.
Technical Analysis
Sumitomo Dainippon Pharma Co
―
Torii Pharmaceutical Co
―
Tsumura & Co
―
Nippon Shinyaku Co., Ltd.
―
SAWAI GROUP HOLDINGS Co., Ltd.
―